SAN DIEGO – Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI), identified for supplying reagents and companies to the life science analysis and biotechnology sectors, has indicated its anticipated complete income for the fiscal 12 months 2024.
Shares fell 5% in after-hours commerce Wednesday.
The corporate’s preliminary year-end outcomes, that are topic to plain year-end changes, counsel that its income is anticipated to align with the mid-point of its beforehand forecasted vary of $255 million to $265 million.
This projection is positioned within the neighborhood of the consensus estimate, which predicts a fiscal 12 months income of roughly $260.78 million.
This text was generated with the help of AI and reviewed by an editor. For extra info see our T&C.
People are feeling more and more downbeat in regards to the financial outlook. Some Wall…
President Trump backed away from his threats to take away Federal Reserve Chair Jerome Powell.…
(Bloomberg) -- Federal worker pension advantages are set to be pared again in Republicans’ big…
Eric Thayer/Bloomberg by way of Getty Photos The U.S. GDP is anticipated to have grown…
By Francesco Canepa, Jan Strupczewski and Leika Kihara WASHINGTON (Reuters) -International policymakers gathering in Washington…
The bosses of 4 of Britain’s greatest banks are secretly urging the chancellor to ditch…